JACK W CALLICUTT

CIK 1266773 · Chief Financial Officer · last filed 2026-01-21

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$20.3K

Companies

2

Total Filings

32

Lifetime Open-Market Net

-$3.98M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GALT Chief Financial Officer 7,614 $2.67 $20.3K -$3.98M 24 2026-01-21
GALECTIN THERAPEUTICS INC (GALTW) Delisted Chief Financial Officer 1,260 $6.2K 7 2016-12-06

Recent Filings · Page 3 of 4

32 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-06-04 GALT Mixed -$192.7K EDGAR
2018-05-24 GALT Grant (A) $0 EDGAR
2018-04-06 GALT Mixed -$13.8K EDGAR
2018-01-17 GALT Grant (A) $0 EDGAR
2016-12-06 GALECTIN THERAPEUTICS INC (GALTW) Delisted Grant (A) $0 EDGAR
2016-01-22 GALECTIN THERAPEUTICS INC (GALTW) Delisted Grant (A) $0 EDGAR
2015-02-02 GALECTIN THERAPEUTICS INC (GALTW) Delisted Grant (A) $0 EDGAR
2014-08-15 GALECTIN THERAPEUTICS INC (GALTW) Delisted Buy (P) +1,000 $4.5K EDGAR
2014-01-24 GALECTIN THERAPEUTICS INC (GALTW) Delisted Grant (A) $0 EDGAR
2013-11-19 GALECTIN THERAPEUTICS INC (GALTW) Delisted Buy (P) +260 $1.6K EDGAR
Showing 2130 of 32
Page 3 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.